These evidences have led to the hypothesis that laminin binding matriglycan is a tumor suppressor and increasing expression of matriglycan could be a new approach of cancer treatment by inhibiting or reducing cancer cells’ invasive and metastatic potential. Here, LAMB2 is linked to cancer.